United States Patent (19 11, 3,923,914 Kobetz Et Al

Total Page:16

File Type:pdf, Size:1020Kb

United States Patent (19 11, 3,923,914 Kobetz Et Al United States Patent (19 11, 3,923,914 Kobetz et al. 145 Dec. 2, 1975 54 CHEMICAL PROCESS OTHER PUBLICATIONS 75 Inventors: Paul Kobetz; Kenneth L. Lindsay, both of Baton Rouge, La. Technique of Organic Chemistry, Vol. VII, pp. 244, 249, Weisberger, Interscience Publishers, London 73) Assignee: Ethyl Corporation, Richmond, Va. (1955). 22 Filed: July 2, 1973 (21 Appl. No.: 375,871 Primary Examiner-Delbert E. Gantz Assistant Examiner-Joseph A. Boska Attorney, Agent, or Firm-Donald L. Johnson; John F. I52) U.S. Cl.............................................. 260/658 R Sieberth; Edgar E. Spielman, Jr. 51) Int. Cl.’.......................................... CO7C 17/20 58) Field of Search ................................. 260/658 R 56) References Cited (57) ABSTRACT UNITED STATES PATENTS A process is disclosed for preparing dibromomethane 2,553,518 5/1951 Lake et al....................... 260/658 R from the reaction of, in the presence of an inert sol 2,675,413 4/1954 Ballard et al.................... 260/658 R vent, alkali metal bromide and dihalomethane. FOREIGN PATENTS OR APPLICATIONS 10 Claims, No Drawings 1,127,345 9/1968 United Kingdom............. 260/658 R 3,923,914 2 the production of dibromomethane from the reaction CHEMICAL PROCESS of dichloro or chlorobromomethane and alkali metal bromide was fraught with difficulty as the equilibrium BACKGROUND OF THE INVENTION of the reaction(s) was shifted far to the left. It has now Brominated hydrocarbons are very valuable com been discovered that the equilibrium of the reaction(s) pounds as they are truly of a multipurpose nature. For can be shifted far to the right by the utilization of a example, methylene bromide may be used as an ingre unique solvent which results in high alkali metal bro dient in fire extinguishing fluids or as a fire retardant; it mide utilization, i.e., up to 60 percent. also may be used as a fluid for gauges and as a heavy Generally speaking, the solvent utilized in the pro liquid in solid separations based upon differences in O cess of this invention may be described as a solvent specific gravity. which is inert to the reaction mixture and which is ca Recognizing the unique value of brominated hydro pable of substantially dissolving the reactants and the carbons, many processes for their production have brominated hydrocarbon products while not substan been developed. U.S. Pat. No. 1,891,415 discloses a tially dissolving the alkali metal chloride by-product. method wherein bromine is reacted with aluminum in a 15 By not substantially dissolving the alkali metal chloride closed system to form molten aluminum bromide which as it is produced it is theorized, though this invention is is then fed directly into reaction with a chlorinated hy not limited to this theory, that the reaction(s) are drocarbon to form the brominated product. This driven to the right. A particularly useful solvent has method, however, suffers from the disadvantage that been found to be one which comprises monoalkyl ether undesirable sludge is formed during the reaction of the 20 of alkylene glycol and water. Preferred monoalkyl aluminum bromide with the chlorinated hydrocarbon. ethers of alkylene glycol for this solvent are those in The formation of sludge is avoided by the method of which the alkyl constituent contains up to three carbon U.S. Pat. No. 2, 120,675 wherein the aluminum bro atoms and in which the alkylene constituent(s) likewise mide is dissolved in an inert solvent such as ethyl bro contain up to three carbon atoms. Exemplary of such mide prior to feeding the solution into reaction with the preferred glycols are monoethyl ether of diethylene chlorinated hydrocarbon. This process, even though it glycol, monopropyl ether of triethylene glycol, mono avoids sludge formation, has the undesirable feature ethyl ether of ethylene glycol, monoethyl ether of prop that a large proportion of inert solvent is employed ylene glycol, monoethyl ether of tripropylene glycol, which reduces the productive capacity of a reactor of monopropylene ether of dipropylene glycol, mono any given size. Further, this reaction suffers from the 30 methyl ether of ethylene glycol, monomethyl ether of disadvantage that it tends to stop far short of complete dipropylene glycol and the like. Most highly preferred consumption of one or both reactants presumably be glycols are monoethyl ether of ethylene glycol and cause of a chemical equilibrium between the reactants monoethyl ether of diethylene glycol. and the products. The volume ratio of the monoalkyl ether of alkylene U.S. Pat. No. 2,553,518 discloses the production of 35 glycol to the water is preferably within the range of organo bromine compounds by reacting hydrogen bro from about 1:1 to about 3:1. Other volumetric ratios mide and centain chlorinated organic compounds in outside of this preferred range, however, may also be the presence of an aluminum halide or borohalide cata used. The main consideration in selecting the volumet lyst. This method is said to overcome the problems ric ratio is whether or not that particular ratio will en mentioned in the earlier two processes; however, this 40 able the reactants and brominated products to be in so process utilizes a catalyst which requires replacing and lution while causing the alkali metal chloride by-pro a hydrogen bromide reactant which is corrosive to con duct to be out of solution as a precipitate. Determina ventional equipment. tion of any particular ratio therefore is easily achieved Therefore, it is an object of this invention to provide by simple tests utilizing the before mentioned criteria a catalyst free process for the production of dibromo 45 of solubility as the determinative factor of whether or methane which does not suffer from any of the above not a particular volumetric ratio is desirable. mentioned disadvantages and which utilizes readily The amount of solvent used in the process of this in available, noncorrosive, inexpensive reactants. vention should be that amount which dissolves the re actants and brominated products while at the same THE INVENTION 50 time maintaining the alkali metal chloride out of solu This invention relates to a process for the production tion as a precipitate. Generally speaking, the amount of of dibromomethane by the reaction of alkali metal bro solvent used will be within the range of from about 1 ml mide and dihalomethane in the presence of an inert Sol to about 20 ml of solvent per gram of reactant used. vent comprising monoalkyl ether of alkylene glycol and Illustrative of the benefits realized when practicing water, wherein at least one of the halogens in the diha 55 the process of this invention with its unique solvent are lomethane is chlorine and the remaining halogen is ei shown in Examples I and II. Examples III and IV are not ther chlorine or bromine, and wherein the alkali metal of this invention and illustrate the low yields realized in the alkali metal bromide has an atomic number when not practicing the process of this invention. greater than 3. EXAMPLE I When the dihalomethane is dichloromethane in the 60 process of this invention the following equilibrium re To a small test tube was added 1.0 g NaBr, 2.0 cc actions take place: CH(OCHCH)OH, 1.0 cc HO and 0.4 g CHCl. 1. CHCl, + MBr streng. CHCIBr + MCIJ The tube was then sealed so as to prevent evaporation 2. CHCIBr +MBratru,CHBr, + MCl of any of the ingredients during the reaction period. wherein M is an alkali metal having an atomic number 65 The sealed tube was then placed in an oil bath at 140°C greater than 3. If the dihalomethane is chloro for 1%hours. After this period of time the tube was bromomethane then equilibrium reaction (2) occurs. cooled to room temperature. The seal of the tube was Prior to the discovery of the process of this invention broken and the ingredients removed. A sodium chlo H 3,923,914 3 4 ride precipitate was noticed and was removed by filtra an excess in the amount of alkali metal bromide being tion. The remaining solid-free filtrate was subjected to preferred. Alkali metal bromide quantities which are NMR analyses. The analysis showed that the dihalome about two times the stoichiometric amount are highly thane content was 15 mole percent CHBr, 55 mole preferred as such amounts aid in keeping the reaction percent CHCIBr, and 35 mole percent CH.Cl. This equilibrium shifted to the right. yield represents a 42.5 percent conversion of sodium No particular order of addition for the reactants is bromide. required. For example, the alkali metal bromide may be added to the dihalomethane used or vice versa with EXAMPLE II no criticality being found. The reactants and solvent The procedure of Example I was followed except that () should be added and thus mixed together at room con 1.0 NaBr, 0.3 g CHCl, 2.0 cc CHOCHCHOH, and ditions as the dihalomethanes are liquid at these condi 1.0 cc HO was added to the test tube. By the analysis tions and are therefore easy to handle. After the reac it was shown that the dihalomethane content com tants have been added, one to the other, and the appro prised 32 mole percent CHBr, 45 mole percent priate reaction conditions are achieved, a reaction per CH.ClBr, and 37 mole percent CH.Cls. This yield cor 15 iod of from about/3 to about 5 hours should be allowed responds to a 54.5 percent conversion of the sodium so as to enable the reactions to reach equilibrium. bromide used. After the reaction has reached equilibrium, it may be desired to recover the methylene bromide in essentially EXAMPLE III pure form.
Recommended publications
  • Nietzsche and Psychedelics – Peter Sjöstedt-H –
    Antichrist Psychonaut: Nietzsche and Psychedelics – Peter Sjöstedt-H – ‘… And close your eyes with holy dread, For he on honey-dew hath fed, And drunk the milk of Paradise.’ So ends the famous fragment of Kubla Khan by the Romantic poet, Samuel Taylor Coleridge. He tells us that the poem was an immediate transcription of an opium-induced dream he experienced in 1797. As is known, the Romantic poets and their kin were inspired by the use of psychoactive substances such as opium, the old world’s common pain reliever. Pain elimination is its negative advantage, but its positive attribute lies in the psychedelic (‘mind- revealing’)1 state it can engender – a state described no better than by the original English opium eater himself, Thomas De Quincey: O just and righteous opium! … thou bildest upon the bosom of darkness, out of the fantastic imagery of the brain, cities and temples, beyond the art of Phidias and Praxiteles – beyond the splendours of Babylon and Hekatómpylos; and, “from the anarchy of dreaming sleep,” callest into sunny light the faces of long-buried beauties … thou hast the keys of Paradise, O just, subtle, and mighty opium!2 Two decades following the publication of these words the First Opium War commences (1839) in which China is martially punished for trying to hinder the British trade of opium to the Chinese people. Though opium, derived from the innocent garden poppy Papavar somniferum, may cradle the keys to Paradise it also clutches the keys to Perdition: its addictive thus potentially ruinous nature is commonly known. Today, partly for these reasons, opiates are mostly illegal without license – stringently so in their most potent forms of morphine and heroin.
    [Show full text]
  • Comparison of Intranasal Versus Intravenous Midazolam for Management of Status Epilepticus in Dogs: a Multi-Center Randomized Parallel Group Clinical Study
    Received: 16 July 2019 Accepted: 9 September 2019 DOI: 10.1111/jvim.15627 STANDARD ARTICLE Comparison of intranasal versus intravenous midazolam for management of status epilepticus in dogs: A multi-center randomized parallel group clinical study Marios Charalambous1 | Holger A. Volk2 | Andrea Tipold2 | Johannes Erath2 | Enrice Huenerfauth2 | Antonella Gallucci3 | Gualtiero Gandini3 | Daisuke Hasegawa4 | Theresa Pancotto5 | John H. Rossmeisl5 | Simon Platt6 | Luisa De Risio7 | Joan R. Coates8 | Mihai Musteata9 | Federica Tirrito10 | Francesca Cozzi10 | Laura Porcarelli11 | Daniele Corlazzoli11 | Rodolfo Cappello12 | An Vanhaesebrouck13 | Bart J.G. Broeckx14 | Luc Van Ham1 | Sofie F.M. Bhatti1 1Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium 2Department of Small Animal Medicine and Surgery, University of Veterinary Medicine Hannover, Hannover, Germany 3Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy 4Department of Clinical Veterinary Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan 5Department of Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia 6Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, Georgia 7Small Animal Referral Centre, Animal Health Trust, Newmarket, United Kingdom 8Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, Missouri 9Department of Clinical Veterinary
    [Show full text]
  • Synthesis of Bromochloromethane Using Phase Transfer Catalysis
    1 SYNTHESIS OF BROMOCHLOROMETHANE USING PHASE TRANSFER CATALYSIS By LANCELOT LUCRETIUS BROOKS Baccalaureus Scientiae Honores-Chemistry, Nelson Mandela Metropolitan University A dissertation submitted in fulfillment of the requirements for the Masters Degree in Chemistry In the Faculty of Science at the NELSON MANDELA METROPOLITAN UNIVERSITY Nov. 2011 Promoter : Dr G. Dugmore Co-Promoter : Prof B. Zeelie 2 DECLARATION I, Lancelot Brooks, hereby declare that the above-mentioned treatise is my own work and that it has not previously been submitted for assessment to another University, or for another qualification. ……………………………….. ……………………….. Mr. L.L. Brooks Date 3 ACKNOWLEDGEMENTS To my promoters Dr. Gary Dugmore, and Prof. Ben Zeelie for their invaluable input, help and guidance. To NRF and NMMU for financial assistance To my parents and brothers for their love and support To Peter, Batsho, Unati, and friends in NMMU chemistry research laboratory, thank you guys. To my dearest fiancée, Natasha, a very special thank you for always being there and supporting me. Love you angel. “And we know that all things work together for good to those who love God, to those who are called according to His purpose” -Romans 8:28. 4 TABLE OF CONTENTS DECLARATION……………………………………………………………………. 2 ACKNOWLEDGEMENTS……………………………………………………………. 3 TABLE OF CONTENTS………………………………………………………………. 4 LIST OF FIGURES…………………………………………………………………….. 8 LIST OF TABLES……………………………………………………………………… 9 LIST OF EQUATIONS………………………………………………………………… 11 SUMMARY……………………………………………………………………………… 12 CHAPTER 1…………………………………………………………………………….. 14 INTRODUCTION………………………………………………………………………. 14 1.1. Technology of leather production……………………………………………….. 14 1.2. Synthesis of TCMTB……………………………………………………………… 17 1.3. Bromine……………………………………………………………………………. 20 1.3.1. Overview……………………………………………………………. 20 1.3.2. Applications of bromine compounds…………..…………………. 22 1.3.2.1. Photography……………………………………………… 22 1.3.2.2.
    [Show full text]
  • Rectal Absorption in Childhood
    RECTAL ABSORPTION IN CHILDHOOD by JOHN WILLIAM ALEXANDER MACKENZIE, M.B., Ch. THESIS SUBMITTED FOR DEGREE OF M.D. UNIVERSITY OF GLASGOW ProQuest Number: 13849818 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 13849818 Published by ProQuest LLC(2019). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 (i) CONTENTS Page Preface, ..« «». ••• ••• (ii) Introduction, ... ... ... 1. The Origins of Rectal Therapy, ... 1. The Present Position, ... ... 6. Investigation: A. The Absorption of Glucose, ... 11. Blood Sugar Studies, ... ... 15. The Glucose Content of the Rectal Washout. 18. The Effect of the Glucose Enema on Nitrogen Metabolism, ... ... 19. B. The Absorption of Sodium Chloride, ... 35. C. The Absorption of Predigested Protein, 41. D. The Absorption of Drugs, ... ... 53. 1. Potassium Bromide, ... ... 55. 2. Sodium Salicylate, ... ... 58. 3. Sulphanilamide, ... ... 65. Discussion. The Range of Substances Absorbed, ... 73. The Path of Absorption, ... ... 76. The Quantity Given, ... ... 80. General Conclusion, ... ... ... 84. General Summary, ... ... ... 86. APPENDIX. 1. Solutions used for Rectal Infusion, 87. 2. Biochemical Methods, ... 89. 3. Bibliography, ... ... 94. (ii) PREFACE The work for this thesis was carried out in the wards and biochemical laboratory of the Royal Hospital for Sick Children, Glasgow.
    [Show full text]
  • Canine Status Epilepticus Care
    Vet Times The website for the veterinary profession https://www.vettimes.co.uk CANINE STATUS EPILEPTICUS CARE Author : Stefano Cortellini, Luisa de Risio Categories : Vets Date : August 2, 2010 Stefano Cortellini and Luisa de Risio discuss emergency management techniques for a condition that can claim the lives of 25 per cent of afflicted dogs – as the quicker the start of treatment, the better the chances of control STATUS epilepticus (SE) is a neurological emergency with a mortality of up to 25 per cent in dogs (Bateman, 1999). SE can be defined as continuous epileptic seizure (ES) activity lasting longer than five minutes, or as two or more ES with incomplete recovery of consciousness interictally. SE has also been defined as continuous seizure activity lasting for 30 minutes or longer. However, emergency treatment to stop the ES should be administered well before the defined 30-minute time. The most common type of SE is generalised tonic-clonic status. When this is prolonged, the tonic- clonic clinical manifestations can become subtle, with only small muscle twitching and altered mentation. This status is called electromechanical dissociation, as continued abnormal electrical activity in the brain persists while the motor manifestations are minimal to absent. In these cases, emergency anti-epileptic treatment is necessary as for tonic-clonic status. SE can be divided into two stages. The first stage is characterised by generalised tonicclonic seizures and an increase in autonomic activity that causes tachycardia, hypertension, 1 / 7 hyperglycaemia, hyperthermia and increased cerebral blood flow. The second stage of SE starts after about 30 minutes and is characterised by hypotension, hypoglycaemia, hyperthermia, hypoxia, decreased cerebral blood flow, cerebral oedema and increased intracranial pressure.
    [Show full text]
  • (19) United States (12) Reissued Patent (10) Patent Number: US RE42,889 E Vazquez Et Al
    USOORE42889E (19) United States (12) Reissued Patent (10) Patent Number: US RE42,889 E Vazquez et al. (45) Date of Reissued Patent: Nov. 1, 2011 (54) O- AND B-AMINO ACID 5,140,011 A 8, 1992 Branca et al. HYDROXYETHYLAMNO SULFONAMIDES 5,194,608 A 3/1993 Toyoda et al. 5,215,967 A 6/1993 Gante et al. USEFUL AS RETROVIRAL PROTEASE 5,223,615 A 6/1993 Toyoda et al. INHIBITORS 5,272,268 A 12/1993 Toyoda et al. 5,278,148 A 1/1994 Branca et al. 5,463,104 A 10/1995 Vazquez et al. (75) Inventors: Michael L. Vazquez, Gurnee, IL (US); 5,475,013 A 12/1995 Talley et al. Richard A. Mueller, Glencoe, IL (US); 5,514,801 A 5/1996 Bertenshaw et al. John J. Talley, St. Louis, MO (US); 5,521,219 A 5/1996 Vazquez et al. Daniel P. Getman, Chesterfield, MO 5,532,215 A 7/1996 Lezdey et al. 5,541,206 A 7/1996 Kempfet al. (US); Gary A. DeCrescenzo, St. Peters, 5,552,558 A 9/1996 Kempfet al. MO (US); John N. Freskos, Clayton, 5,585.397 A * 12/1996 Tung et al. .................... 514,473 MO (US); Robert M. Heintz, Ballwin, H1649 H 5/1997 Barrish et al. MO (US); Deborah E. Bertenshaw, 5,674,882 A 10/1997 Kempfet al. 5,691,372 A 1 1/1997 Tung et al. Brentwood, MO (US) 5,723,490 A 3/1998 Tung 5,744,481 A 4/1998 Vazquez et al. (73) Assignee: G.D.
    [Show full text]
  • Determination of Bromine Number According ASTM D 1159
    SI Analytics-Application report Titration Determination of bromine number according ASTM D 1159 Description This application note describes the determination of the bromine number of petroleum distillates, olefins and similar samples with a bromine number > 1. For bromine numbers < 1 please use the test method for ASTM D 2710 or for aromatic hydrocarbons the coulometric test method ASTM D1492. Instruments Titrator TL 7000 or higher with 10 or 20 ml burette. Electrode Pt 1200, Pt 1400 or KF 1100 and temperature sensor (e.g. W W 5790 NN) Cable L 1 NN (only for Pt 1200 and Pt 1400) Stirrer Magnetic stirrer TM 235 Lab accessory Glass beaker 150 ml or larger with an ice bath or double jacketed titration vessel TZ 1756 with a cryostat. The sample have to be maintained at a temperature between 0 – 5 °C. 50 ml volumetric flask with stopper, 250 ml graduated measuring cylinder 5 ml volumetric pipette or variable one Magnetic stirrer bar 30 mm Reagents 1 Bromide-Bromate, Standard Solution(0.2500 M as Br2) 2 Glacial acetic acid 3 Dichloromethane (as replacement of 1,1,1-trichloroethane) 4 Methanol 5 Sodium thiosulfate solution 0.1 M for standardization of the titrant (optional) 7 Sulfuric acid 1/5 diluted (1 part H2SO4 conc. + 5 parts water) 6 Potassium Iodide solution (150 g/L) for standardization of the titrant (optional) 8 Starch indicator solution of redox electrode Pt 62 (+ WA 50 exchangeable unit) All reagents should be of analytical grade or better. Bromine number ASTM D 1159.docx 1/4 Titration procedure Titration solvent Prepare 1 L of titration solvent by mixing the following volumes of materials: 714 mL of glacial acetic acid, 134 mL of 1,1,1-trichloroethane (or better dichloromethane), 134 mL of methanol, and 18 mL of H2SO4(1 + 5).
    [Show full text]
  • PBPK) Modeling of Metabolic Pathways of Bromochloromethane in Rats
    CORE Metadata, citation and similar papers at core.ac.uk Provided by PubMed Central Hindawi Publishing Corporation Journal of Toxicology Volume 2012, Article ID 629781, 14 pages doi:10.1155/2012/629781 Research Article Physiologically Based Pharmacokinetic (PBPK) Modeling of Metabolic Pathways of Bromochloromethane in Rats W. S. Cuello, 1 T. A. T. Janes, 1 J. M. Jessee,1 M. A. Venecek,1 M. E. Sawyer,2 C. R. Eklund,3 andM.V.Evans3 1 Research Experience for Undergraduate participant, Department of Mathematics, North Carolina State University, Raleigh, NC 27695, USA 2 Department of Mathematics, North Carolina State University, Raleigh, NC 27695, USA 3 National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Office of Research and Development, Research Triangle Park, NC 27709, USA Correspondence should be addressed to M. V. Evans, [email protected] Received 18 January 2012; Revised 27 March 2012; Accepted 30 March 2012 Academic Editor: Kannan Krishnan Copyright © 2012 W. S. Cuello et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Bromochloromethane (BCM) is a volatile compound and a by-product of disinfection of water by chlorination. Physiologically based pharmacokinetic (PBPK) models are used in risk assessment applications. An updated PBPK model for BCM is generated and applied to hypotheses testing calibrated using vapor uptake data. The two different metabolic hypotheses examined are (1) a two-pathway model using both CYP2E1 and glutathione transferase enzymes and (2) a two-binding site model where metabolism can occur on one enzyme, CYP2E1.
    [Show full text]
  • ' -I {\~ 'Lr:R, ~', C, T...J5.--Ia. Rl V{. Rici-...L... FRENCH
    WORLD HEALTH ORGANIZATION MNH/83.7 ORGANISATION MONDIALE D! LA SANTE ..' ,I ORIGINAL: ENGLISH/ t) I'(.AA ... ) ' -I r:r, t......J5.--iA. rl V{. rICI-..... l... FRENCH {\~ ' l ~' , C, .. {.;'.; (,( 0 ' . \"'''-C:.. ~\ ~ ~v '- ' / '~ v- J C; SEVENTH REVIEW OF PSYCHOACTIVE SUBSTANCES FOR INTERNATIONAL CONTROL ) Geneva, 7-11 March 1983 " : CONTENTS INDEXED _, INTRODUCTION 1 SCOPE OF THE MEETING • 2 SOURCES AND NATURE OF DATA REVIEWED 2 REVIEW OF DRUGS FOR INTERNATIONAL CONTROL 2 i 4.1 Alfentanil 2 . 4.2 Chloral hydrate • 3 :4.3 Paraldehyde • • • 3 4.4 Potassium bromide 3 ' 4.5 Buprenorphine 3 ,4.6 Butorphanol • 4 4.7 Cyclazocine 4 4.8 Nalbuphine 4 4.9 Pentazocine • • • • 4 WHO'S CANCER PAIN RELIEF PROGRAMME 5 .; CONSIDERATIONS OF FUTURE PROGRAMMES • • • • 5 LIST OF PARTICIPANTS 6 ~~ EX I ...... 8 INTRODUCTION Dr Halfdan Mahler, Director-General of WHO, Dr Lu Rushan, Assistant tor-General of WHO, welcomed the participants in this meeting and expressed the concern of Tegarding the process of reviewing substances for international control. Dr Norman Sartorius, Director, Division of Mental Health WHO, discussed with the ipants the conditions in the developing nations which must be considered in reaching regarding the recommendation of substances for international control. He referred ifically to a gradual change in the attitude of people towards pain. No longer is pain as a natural accompaniment of disease. The effective analgesics, widely available the developed countries of the world, must become available for legitimate medical needs P~ tients in the developing countries. This availability of analgesic drugs must however into account the fact that many such substances are capable of producing dependence and • consequence significant public health and social problems.
    [Show full text]
  • Studies on Isotope Separation of Lithium by Electromigration in Fused Lithium Bromide and Potassium Bromide Mixture, (II) Composition of Salt in Anode Compartment
    Journal of NUCLEARSCIENCE and TECHNOLOGY,7 (10), p. 522~526 (October 1970). Studies on Isotope Separation of Lithium by Electromigration in Fused Lithium Bromide and Potassium Bromide Mixture, (II) Composition of Salt in Anode Compartment Yoshinobu YAMAMURA* and Shin SUZUKI* Received May 13, 1970 Accurate knowledge on the salt composition in the anode compartment is indispensable when 6Li is to be highly enriched by electromigration in fused LiBr-KBr mixture. A study was made on the dependence on temperature shown by the salt composition in the anode com- partment. It was observed that sustained electromigration led to a salt composition in the anode compartment that was determined by the prevailing temperature. The composition was observed for various temperatures between 380- and 740-C: In terms of the ratio Li/K in chemical equivalent, the values were 1.31 at 380-C, 1.29 at 420-C, 1.31 at 460-C, 1.41 at 500-C, 1.76 at 540-C, 1.82 at 580-C, 1.95 at 620-C, 2.16 at 680-C and 2.34 at 740-C. These results can be explained by assuming that the fused LiBr-KBr mixture is a system composed of two simple salts and their eutectic, and that at temperatures below 550-C, which is the melting point of LiBr, LiBr and KBr are dissolved in fused eutectic, while KBr is dissolved in the fused eutectic and LiBr at temperatures between 550- and 738-C, which latter is the melting point of KBr. I. INTRODUCTION . EXPERIMENTAL In a previous study(1), one of authors suc- 1.
    [Show full text]
  • IIIHIIII US005202462A United States Patent (19) (11) Patent Number: 5,202,462 Yazawa Et Al
    IIIHIIII US005202462A United States Patent (19) (11) Patent Number: 5,202,462 Yazawa et al. 45) Date of Patent: Apr. 13, 1993 (54) PROCESS FOR PRODUCING A HALOMETHYL PVALATE FOREIGN PATENT DOCUMENTS 75) Inventors: Naoto Yazawa, Shizuoka; Keinosuke 224.5457 3/1973 Fed. Rep. of Germany . Ishikame, Tokyo, both of Japan 3152341 6/1988 Japan ................................... 560/236 73) Assignee: hara Chemical Industry Co., Ltd., OTHER PUBLICATIONS Tokyo, Japan Chemical Abstracts, vol. 107, No. 17, Oct. 26, 1987, Andreev et al: "Chloromethyl pivalate." p. 664, Ab (21) Appl. No.: 920,529 stract No. 153938q. (22 Filed: Jul. 28, 1992 Chemical Abstracts, vol. 101, No. 23, Dec. 3, 1984, Binderup et al: "Chlorosulfates as reagents in the syn Related U.S. Application Data thesis of carboxylic acid esters . ', p. 563, Abstract 63 Continuation of Ser. No. 686,921, Apr. 18, 1991, aban No. 210 048b. doned. Primary Examiner-Arthur C. Prescott (30) Foreign Application Priority Data Attorney, Agent, or Firm-Oblon, Spivak, McClelland, Maier & Neustadt Apr. 20, 1990 JP Japan .................................. 2-104544 (51) Int. Cl* ... co7C 69/62 57 ABSTRACT 52) U.S. C. ............... A process for producing a halomethyl pivalate which 58) Field of Search ......................................... S60/236 comprises reacting an aqueous solution of a metal salt of pivalic acid with a dihalomethane selected from the (56) References Cited group consisting of bromochloromethane, chloroi U.S. PATENT DOCUMENTS odomethane and bromoiodomethane in the presence of 3,992,432 11/1976 Napier ................................. 560/236 a phase transfer catalyst. 4,421,675 12/1983 Sawicki. ... 560/236 4,699,991 0/1987 Arkles ................................. 560/236 14 Claims, No Drawings 5,202,462 1 2 According to the present invention, it is essential to PROCESS FOR PRODUCING A HALOMETHYL have a phase transfer catalyst present during the reac PVALATE tion of the aqueous solution of metal salt of pivalic acid with the dihalomethane.
    [Show full text]
  • United States Patent Office Patented Aug
    3,524,872 United States Patent Office Patented Aug. 18, 1970 1. 2 3,524,872 prepared ammonium thiocyanate to produce a clean, PRODUCTION OF METHYLENE BIS THOCYA slightly off-white product of methylene bis thiocyanate NATE FROM AMMONUM THIOCYANATE AND DHALO METHANES (MT). Joseph Matt, Chicago, Ill., assignor to Nalco Chemical CONTROL OF THE pH Company, Chicago, Ill., a corporation of Delaware The instant reactant, NHSCN, much more than its No Drawing. Filed May 15, 1967, Ser. No. 638,624 alkali metal cousins, is susceptible to polymerization. It Int, C. C07 c 161/02 is believed that when the pH of the reaction mixture is U.S. C. 260-454 9 (Caims less than 6 and to a certain extent less than 6.2, then ammonia is present in the reaction mixture as NH3 or O NH, and the unstable HSCN polymerizes to a dark ABSTRACT OF THE DISCLOSURE brown or red mass. The product yield is cluttered with The present invention relates to an improvement in the a polyymeric by-product if the initial pH is below 6. general process of producing methylene bis thiocyanate Conversely, where the pH is >6.5 ranging up into a (MT) by the following equation: basic medium, the polymer formation in the product is 5 apparently chargeable to increased sensitiveness of the 2NHCNS -- CH2 X2 - CH(SCN)2 + NHX desired methylene bis thiocyanate and the unstable mono (AT) (MT) halide intermediate in the reaction medium also giving Timm polymer by-product. Thus, beset by different polymer formation problems Applicant has now found that in dealing with the for 20 either way on the pH scale, the present process has Sur merly non-preferred reactant ammonium thiocyanate, cer mounted these difficulties by finding a critical initial pH tain critical pH limitations are necessary in order to to make available as a reactant the cheaper but previously achieve operable or improved results as related to inhibi scorned ammonium thiocyanate (AT).
    [Show full text]